CLINICAL_TRIALS
trial_result
· 2017-07-28
Clinical Trial Update: TRUST-2: Safety and Efficacy of Intravenous Remodulin® in Patients in India With Pulmonary Arterial Hypertension (PAH) [Phase 4]
Summary
Phase 4 trial update on intravenous Remodulin (treprostinil) in Indian PAH patients; study completed with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: United Therapeutics | Conditions: Pulmonary Arterial Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2017-07-28